Asia‐inclusive global development of pevonedistat: Clinical pharmacology and translational research enabling a phase 3 multiregional clinical trial-Reference-Cited by-同舟云学术

Asia‐inclusive global development of pevonedistat: Clinical pharmacology and translational research enabling a phase 3 multiregional clinical trial

Published:2021-02-02 Issue:3 Volume:14 Page:1069-1081
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Zhou Xiaofei¹,Friedlander Sharon¹,Kupperman Erik¹,Sedarati Farhad¹,Kuroda Shingo²,Hua Zhaowei³,Yuan Ying¹,Yamamoto Yuka²,Faller Douglas V.¹,Haikawa Kazue²,Nakai Katsuhiko²,Bowen Sharon¹,Dai Yi⁴,Venkatakrishnan Karthik¹^ORCID

Affiliation:

1. Millennium Pharmaceuticals, Inc. (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited) Cambridge MA USA

2. Takeda Pharmaceutical Company Limited Tokyo Japan

3. Alnylam Pharmaceuticals Inc. Cambridge MA USA

4. Takeda Pharmaceutical Company Limited Beijing China

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12972

Reference70 articles.

1. Toward Optimum Benefit‐Risk and Reduced Access Lag For Cancer Drugs in Asia: A Global Development Framework Guided by Clinical Pharmacology Principles

2. Factors Affecting Drug-Development Strategies in Asian Global Clinical Trials for Drug Approval in Japan

3. ICH E5.Ethnic factors in the acceptability of foreign clinical data E5(R1) 1998.https://database.ich.org/sites/default/files/E5_R1__Guideline.pdf. Accessed November 12 2020.

4. ICH E17.General principles for planning and design of multi‐regional clinical trials E17 2017.https://database.ich.org/sites/default/files/E17EWG_Step4_2017_1116.pdf. Accessed November 12 2020.

5. Targeting NEDD8-Activated Cullin-RING Ligases for the Treatment of Cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of small molecule inhibitors of neddylation catalyzing enzymes for anticancer therapy;Biomedicine & Pharmacotherapy;2024-10

2. Ubiquitin-like modification dependent proteasomal degradation and disease therapy;Trends in Molecular Medicine;2024-06

3. Substrate and Functional Diversity of Protein Lysine Post-translational Modifications;Genomics, Proteomics & Bioinformatics;2024-02-01

4. Real-world Effectiveness of Azacitidine in Treatment-Naive Patients With Higher-risk Myelodysplastic Syndromes;Clinical Lymphoma Myeloma and Leukemia;2023-12

5. The neddylation inhibitor MLN4924 inhibits proliferation and triggers apoptosis of oral cancer cells but not for normal cells;Environmental Toxicology;2023-09-13